菜单

Supply Chain Intelligence about:

Novartis Pharma AG

企业页面   Switzerland

See Novartis Pharma AG's products and customers

成千上万家像您这样的公司使用磐聚网搜索供应商和竞争对手。

轻松使用贸易数据

290美国进口货运
US
13,801 南美货运信息
南美

以公司为组织的美国海关记录

290 U.S. shipments available for Novartis Pharma AG, updated weekly since 2007
日期 供应商 客户 详细信息 43 more fields
2023-04-17 Novartis Pharma AG
Alcon Research
XXXXXXXXXXXX XX X XXX XXXXX
货运提单
2023-04-10 Novartis Pharma AG
Alcon Research
XXXXXXXXXXXX XX X XXX XXXXX
货运提单
2022-11-25 Novartis Pharma AG
Sandoz Inc.
XXXXXXXXXXXXXXXXXXX XXX XXXXX XXXX XXXXXXXXXXXXXXXXXXX XXX XXXXX XXXX XXXXXXXXXXXXXXXXXXX XXX XXXXX XXXX XXXXXXXXXXXXXXXXXXX XXX XXXXX XXXX XXXXXXXXXXXXXXXXXXX XXX XXXXX XXXX XXXXXXXXXXXXXXXXXXX XXX XXXXX XXXX
货运提单
货运数据显示一个公司交易什么产品或者更多。 了解更多信息

Explore trading relationships hidden in supply chain data

Contact information for Novartis Pharma AG

 
地址
Lichtstrasse 35, Basel, Switzerland, 4002
 
 

Sample Bill of Lading

14,136 shipment records available

Date
2023-04-17
Shipper Name
Novartis Pharma Ag
Shipper Address
Lichtstrasse 35, Basel, Switzerland, 4002
Consignee Name
Alcon Research, Llc
Consignee Address
ATTENTION MELINDA SAENZ 6201 SOUTH FREEWAY FORTH WORTH TX 76134 UNITED STATES
Weight
4377
Weight Unit
KG
Weight in KG
4377.0
Quantity
22
Quantity Unit
PKG
Measure Unit
CM
Shipment Origin
Switzerland
Details
4,377.0 kg
From port: Antwerp, Belgium
To port: Houston, Houston, Texas
Place of Receipt
Antwerpen
Foreign Port of Lading
Antwerp, Belgium
U.S. Port of Unlading
Houston, Houston, Texas
U.S. Destination Port
Houston, Houston, Texas
Commodity
XXXXXXXXXXXX XX X XXX XXXXX
Container
MSDU8314986
Marks Description
XX XXXXXX XXXXXXXX XXXXXXXX
Carrier Name
DSV OCEAN TRANSPORT
Vessel Name
MAERSK MONTANA
Voyage Number
313W
Bill of Lading Number
DSVFANR0269147
Master Bill of Lading Number
MEDUAW131711
Lloyd's Code
9305312
HTS Codes
HTS 8483.90

Recent Panjiva Research about Novartis Pharma AG

20161123-uk-ppi

The Old Ones Are the Best Ones as P-PI Drug Imports Grow

U.S. imports of proton-pump inhibitor drugs to treat gastrointestinal disease increased 45% in October on a year earlier, a similar rate to that seen for statins and anticonvulsants. Around half the growth in the three months to October 31 vs. the same period a year earlier came from omeprazol... Read more →